Blue Horizon International does not offer or provide medical treatment or see patients within the United States. Our cellular and exosome products are investigational and are not approved by the U.S. FDA. This website is for informational and educational purposes only and is not medical advice.

Style Sampler

Layout Style

Patterns for Boxed Mode

Backgrounds for Boxed Mode

All fields are required.

Close Appointment form

About Blue Horizon International

  • Home
  • About Blue Horizon International

About Blue Horizon International

Blue Horizon International (BHI) is a healthcare consulting company founded in 2009 by orthopedic surgeon Brian Mehling, MD. BHI combines scientific research, education, and philanthropy.

Through BHI Therapeutic Sciences, BHI supports investigational research in stem cell science and regenerative medicine, conducted under Institutional Review Board oversight and in collaboration with academic and clinical partners. Through the Blue Horizon Charitable Foundation, BHI supports access to medical care for underserved children and adults.

Blue Horizon International does not provide medical treatment or patient care in the United States. Its cellular products are investigational, have not been shown to be safe or effective for any disease or condition, and are not approved by the U.S. Food and Drug Administration.